GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.295
-0.007 (-2.19%)
At close: Feb 21, 2025, 4:00 PM
0.287
-0.008 (-2.61%)
After-hours: Feb 21, 2025, 7:58 PM EST
Company Description
GlycoMimetics, Inc., a biotechnology company, engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.
GlycoMimetics, Inc.
| Country | United States |
| Founded | 2003 |
| IPO Date | Jan 10, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Harout Semerjian |
Contact Details
Address: P.O. Box 65 Monrovia, Maryland 21770 United States | |
| Phone | 240 243 1201 |
| Website | glycomimetics.com |
Stock Details
| Ticker Symbol | GLYC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001253689 |
| CUSIP Number | 38000Q102 |
| ISIN Number | US38000Q1022 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Harout Semerjian | Chief Executive Officer, President and Director |
| Rachel K. King | Co-Founder and Director |
| Brian M. Hahn | Senior Vice President and Chief Financial Officer |
| Stephanie R. Irish CPA | Vice President of Accounting |
| Christian B. Dinneen-Long | General Counsel and Company Secretary |
| Bruce Johnson | Senior Vice President and Chief Commercial Officer |
| Chinmaya Rath | Senior Vice President and Chief Business Officer |
| Shantha Tyavanagimatt Ph.D. | Senior Vice President of Technical Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 18, 2025 | S-4 | Filing |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 14, 2025 | 425 | Filing |
| Feb 14, 2025 | 8-K | Current Report |
| Feb 13, 2025 | 10-K | Annual Report |
| Jan 31, 2025 | 8-K | Current Report |
| Jan 13, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 13, 2025 | 8-K | Current Report |
| Dec 26, 2024 | 8-K | Current Report |
| Nov 27, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |